The agency says the current policies, guidelines and controls for the cybersecurity and privacy of genomic data are inadequate and asks the public to comment on proposed use cases and protections.
Personalized medicine is constantly evolving, and the technologies it relies on are advancing rapidly. In this environment, the associated challenges are numerous and complex. Overcoming them often requires fresh eyes and multiple perspectives.